APA citiranje

Kampa-Schittenhelm, K. M., Heinrich, M. C., Akmut, F., Döhner, H., Döhner, K., & Schittenhelm, M. M. (2013). Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms. BioMed Central.

Citação norma Chicago

Kampa-Schittenhelm, Kerstin Maria, Michael Charles Heinrich, Figen Akmut, Hartmut Döhner, Konstanze Döhner, and Marcus Matthias Schittenhelm. Quizartinib (AC220) Is a Potent Second Generation Class III Tyrosine Kinase Inhibitor That Displays a Distinct Inhibition Profile against Mutant-FLT3, -PDGFRA and -KIT Isoforms. BioMed Central, 2013.

MLA citiranje

Kampa-Schittenhelm, Kerstin Maria, et al. Quizartinib (AC220) Is a Potent Second Generation Class III Tyrosine Kinase Inhibitor That Displays a Distinct Inhibition Profile against Mutant-FLT3, -PDGFRA and -KIT Isoforms. BioMed Central, 2013.